Hele Everaus

1953 -

country of citizenship: Estonia

languages spoken, written or signed: Russian, English

educated at: Tartu Tamme Gymnasium, University of Tartu

occupation: hematologist, politician, researcher

award received: Order of the Estonian Red Cross, University of Tartu Badge of Distinction, University of Tartu Grand Medal

position held: member of the Riigikogu

Hele Everaus (born 5 January 1953 in Tartu) is an Estonian medical scientist, physician and politician. She has been member of XIV Riigikogu. In 1993, she was the first to perform bone marrow transplantation in the Baltic States. Source: Wikipedia (en)

Series

There is nothing here

Create a new serie

Works

There is nothing here

Create a new work

Articles 27

Date

Title

Authors

2020-06-29

The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia

Markus Pfirrmann, Anna Turkina, Tomasz Sacha, Perttu Koskenvesa, Hele Everaus, Edgar Faber, Daniela Žáčková
2019-07-11

Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia

Heikki Kuusanmäki, Merja Heinäniemi, Satu Mustjoki, Hele Everaus, Mika Kontro, Petri Pölönen
2019-07-19

Increasing incidence and survival of corpus uteri cancer in Estonia over the past two decades

Hele Everaus, Piret Veerus, Kaire Innos, Kristiina Ojamaa
2018-11-07

Trends in cervical cancer incidence and survival in Estonia from 1995 to 2014

Kristiina Ojamaa, Hele Everaus, Piret Veerus, Kaire Innos
2017-02-01

Established Human Cell Lines as Models to Study Anti-leukemic Effects of Flavonoids

Katrin Sak, Hele Everaus
2016-02-18

Sulfotransferase 1A1 as a Biomarker for Susceptibility to Carcinogenesis: From Molecular Genetics to the Role of Dietary Flavonoids

Katrin Sak, Hele Everaus
2016-08-04

Potentiation of luteolin cytotoxicity by flavonols fisetin and quercetin in human chronic lymphocytic leukemia cell lines

Katrin Sak, Hele Everaus
2016-11-17

Time Trends in Ovarian Cancer Survival in Estonia by Age and Stage

Kaire Innos, Hele Everaus, Piret Veerus, Kristiina Ojamaa
2016-08-19

Acute de novo Leukemia in Estonia and Western Sweden 1982-2006: Positive Trend in the Survival of Acute Leukemia over 25 Years

Erik Holmberg, Hele Everaus, Katrin Palk, Dick Stockelberg
2016

Nanotechnological approach to improve the bioavailability of dietary flavonoids with chemopreventive and anticancer properties

Katrin Sak, Hele Everaus
2015-01-01

Role of flavonoids in future anticancer therapy by eliminating the cancer stem cells

Katrin Sak, Hele Everaus
2015-05-19

Chemomodulating Effects of Flavonoids in Human Leukemia Cells

Katrin Sak, Hele Everaus
2015-01-01

Multi-Target Cytotoxic Actions of Flavonoids in Blood Cancer Cells

Katrin Sak, Hele Everaus
2015-07-13

Multi-Target Cytotoxic Actions of Flavonoids in Blood Cancer Cells

Katrin Sak, Hele Everaus
2014-02-11

Hematopoietic stem cell transplantation (HSCT) as an example of personalized approach in the management of individual disease.

Hele Everaus
2014-02-11

Closer to personalized approach through accepting the gender differences in medicine

Hele Everaus
2013-04-18

A mathematical model of natural killer cell activity

Hele Everaus
2013-02-09

Sequential population-based studies over 25 years on the incidence and survival of acute de novo leukemias in Estonia and in a well-defined region of western Sweden during 1982-2006: a survey of patients aged ≥65 years

Erik Holmberg, Jack Kutti, Soodabeh Safai-Kutti, Katrin Palk, Mirja Varik, Hele Everaus, Dick Stockelberg
2012-09-18

Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients

Joanne Bowen, A Al-Azri, Hele Everaus, Judith E Raber-Durlacher
2011-08-13

The incidence and survival of acute de novo leukemias in Estonia and in a well-defined region of western Sweden during 1997-2001: a survey of patients aged 16-64 years.

Erik Holmberg, Jack Kutti, Soodabeh Safai-Kutti, Katrin Palk, Mirja Varik, Hele Everaus, Dick Stockelberg, Ene Luik, Iige Viigimaa
2010-01-13

The incidence and survival of acute de novo leukemias in Estonia and in a well-defined region of western Sweden during 1997-2001: a survey of patients aged >or=65 years.

Erik Holmberg, Jack Kutti, Soodabeh Safai-Kutti, Katrin Palk, Mirja Varik, Hele Everaus, Dick Stockelberg, Ene Luik, Iige Viigimaa
2006-10-25

Changes in the natural history of renal cancer: comparison of Estonian data from the periods 1986-1988 and 1996-1998.

Hele Everaus
2006-06-01

The effect of allogeneic stem cell transplantation on outcome in younger acute myeloid leukemia patients with minimal residual disease detected by flow cytometry at the end of post-remission chemotherapy.

Hele Everaus
2005-03-01

Flow cytometric immunophenotyping including Bcl-2 detection on fine needle aspirates in the diagnosis of reactive lymphadenopathy and non-Hodgkin's lymphoma

Hele Everaus
2004-04-01

Nongenomic effects of 17beta-estradiol--diversity of membrane binding sites

Katrin Sak, Hele Everaus
2004-05-01

The incidence and survival of acute de novo leukaemias in Estonia and in a well defined region of Western Sweden during 1982-1996: a survey of patients aged 16-64 years

Erik Holmberg, Jack Kutti, Soodabeh Safai-Kutti, Katrin Palk, Mirja Varik, Hele Everaus, Dick Stockelberg, Ene Luik
2003-04-01

Involvement of P2Y receptors in the differentiation of haematopoietic cells

Katrin Sak, Hele Everaus

Human - wd:Q12363696

Welcome to Inventaire

the library of your friends and communities

learn more